Gut Microbiota-Derived Trimethylamine N-Oxide Predicts the Extent of Myocardial Fibrosis Six Months After ST-Segment Elevation Myocardial Infarction: a Prospective Cohort Study

Authors

  • Dr. Harish Kumar K.S, Dr. Prasanth. G, Dr. Aruni. I. S Author

DOI:

https://doi.org/10.48047/

Keywords:

Trimethylamine N-oxide; Gut microbiota; Cardiac MRI; Myocardial fibrosis; STEMI; Translational microbiology-cardiology.

Abstract

Gut microbial metabolite trimethylamine N-oxide (TMAO) is linked to adverse cardiovascular outcomes and experimental cardiac fibrosis. Whether early post-infarction TMAO concentrations predict objectively-measured left-ventricular (LV) fibrosis in humans remains unknown. 

Downloads

Download data is not yet available.

Downloads

Published

2021-06-15

Issue

Vol. 12 No. 6 (2021): volume 12 issue 6 (2021)

Section

Articles